Assessment of the potential heart donor: a role for biomarkers?

Vamsidhar B Dronavalli1, Nicholas R Banner, Robert S Bonser

  • 1Department of Cardiothoracic Surgery, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham B15 2TH, United Kingdom.

Insights

Biomarkers could improve donor heart selection, addressing the critical shortage and preventing early graft failure. This review explores cardiac biomarkers for better donor heart assessment and transplantation outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Biomarker Research

Background:

  • Donor heart supply is insufficient for demand, leading to patient mortality.
  • Current donor heart assessment methods are inadequate, resulting in graft failure.
  • Unused donor hearts may be declined due to concerns about poor function.

Purpose of the Study:

  • To review the current status of biomarkers in assessing donor hearts for transplantation.
  • To explore the potential of biomarkers in improving the selection of suitable donor hearts.
  • To identify biomarkers that can predict early graft failure in recipients.

Main Methods:

  • Literature review of existing studies on donor heart assessment.
  • Analysis of the role of cardiac biomarkers in diagnosing and risk-stratifying cardiac conditions.
  • Examination of specific biomarker categories including cardiac troponins, cytokines, inflammatory markers, natriuretic peptides, and intracellular proteins.

Main Results:

  • Biomarkers are established tools for diagnosing and risk-stratifying myocardial infarction, acute coronary syndromes, and heart failure.
  • Several biomarker categories show potential discriminant value for donor heart assessment.
  • Current assessment methods for donor hearts are insufficient to predict post-transplant function.

Conclusions:

  • Biomarkers offer a promising avenue to enhance donor heart selection accuracy.
  • Improved donor heart assessment using biomarkers could increase transplantation rates and reduce graft failure.
  • Further research into specific cardiac biomarkers is warranted to optimize donor heart utilization and recipient outcomes.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
537
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
947